Schedule 13D ownership disclosure

Vilacto Bio Inc.

Security class unavailable

Event date: 2017-02-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,000,000
Percent of class
83.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001663577-17-000123
Form type
SC 13D
Filer
Andersen Gert
CIK
CIK 1703721
Filed
Apr 18, 2017
Reporting period
Feb 21, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub